New York State Expired 150,000 Misoprostol Doses
The state has confirmed it will destroy $112,000 worth of medication that was never distributed.
Updated on Oct. 6, 2026 in Pregnancy
Live Poll
Do you trust your local government to effectively manage emergency supply stockpiles?
New York has let a stockpile of 150,000 misoprostol pills expire without issuing any for patient use. The state acquired the medication in 2023 for $112,000 but now plans to destroy the entire supply.
Why it matters
The stockpile was initially created as a contingency measure amid legal uncertainty regarding mifepristone access. With current access remaining stable, the state has opted to discard the reserve rather than restock it.
The stockpile consisted of 12,500 doses, each containing 12 pills, acquired for $112,000. While medication abortion accounted for 63% of abortions nationally in 2023, none of this state-held inventory reached patients.
The players
New York State Department of Health
The state agency responsible for overseeing public health initiatives and managing medical supply stockpiles.
Cencora
A global pharmaceutical wholesaler that supplies medications and health products to public and private health entities.
Supreme Court of the United States
The highest federal court which issued rulings impacting the legal availability of medication abortion nationwide.
The details
New York sourced the medication from drug wholesaler Cencora to safeguard reproductive health access during high-stakes litigation. The pills have been held in a secure, climate-controlled location since their 2023 purchase. Following the Supreme Court's dismissal of the Texas mifepristone case and the maintenance of telehealth access, the state determined that maintaining the reserve was no longer necessary.
Timeline
New York acquired 150,000 misoprostol pills in 2023.
The Supreme Court dismissed the Texas mifepristone case in 2024.
The Supreme Court ruled to keep mifepristone available via telehealth in May 2026.
The pills were confirmed expired as of October 2026.
The Home Front
This development follows the precedent set by the 2024 Supreme Court dismissal of the Texas mifepristone case, which clarified national access rules. The move reflects a broader trend among states re-evaluating the necessity of emergency medication reserves following stabilized federal access regulations.
Residents should continue to rely on their established healthcare providers or pharmacies for accessing prescribed reproductive medications. Because this stockpile was held by the state for public contingency and not for direct consumer distribution, no action is required for individual home medicine cabinets.
The takeaway
The expiration of this stockpile reflects the shifting legal landscape for medication access rather than a change in healthcare availability. Families should continue to consult with their physicians for all current medical prescription needs.
Further reading
For more information on current guidance, visit Pregnancy.
Live Poll
Do you trust your local government to effectively manage emergency supply stockpiles?
